Dr Eric Verdin of The Buck Institute for Researc
Author: Michael
Protect Animal Health and Rejuvenate Bio have ann
Promising data from Phase 2 study in myelodyspla
Company continues to advance NLRP3 neuroinflamma
Antag lands €80m to advance GIPR antagonist ap
World’s largest longevity event combines longe
Funding call for innovative scientific proposals